Navigation Links
The Hanover Extends Schools Program, Making the Grade in GA, KS, MD, and VA
Date:6/3/2008

nberg, commercial lines business president at The Hanover. "Our program offers both the specialized coverages and access to dynamic industry professionals knowledgeable of the business who can work closely with our agent partners need to properly insure their school clients."

The Hanover's agent partners have successfully offered Avenues Education Advantage to local schools since 2006 in Indiana, Kentucky, Ohio, Massachusetts, Michigan, Minnesota, New Hampshire and Tennessee.

Avenues Education Advantage is part of a growing list of industry-specific programs being offered by The Hanover, which also includes niche programs for businesses within the healthcare, hospitality, real estate, marina, moving and storage, jewelry and furrier markets.

The Hanover's niche programs complement an already strong commercial lines offering, giving agent partners unique access to a total solution that meets the broad coverage needs of businesses throughout the country.

For more information, agents can contact one of The Hanover's local branch offices or visit the company at http://www.hanover.com.

About The Hanover

The Hanover Insurance Group, Inc. (NYSE: THG), based in Worcester, Mass., is the holding company for a group of insurers that includes The Hanover Insurance Company, also based in Worcester; Citizens Insurance Company of America, headquartered in Howell, Mich., and their affiliates. The Hanover offers a wide range of property and casualty products and services to individuals, families and businesses through an extensive network of independent agents, and has been meeting its obligations to its agent partners and their customers for more than 150 years. Taken as
'/>"/>

SOURCE The Hanover Insurance Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off States Existing Six-Year Surcharge Period
2. American Italian Pasta Company Extends Line of Healthier Pastas With Heartland(R) Perfect Balance
3. The Oregon Clinic Extends Patient Care Services Across Metro Portland with Time Warner Telecoms Metro Ethernet Service
4. HHS Extends Comment Period on Proposed MUP/HPSA Rule
5. Keith Denner Extends Current Technologys Chairman and CEO Options
6. Parker Extends Precise Medical Seal Capability; Acquires Hi-Tech Group Companies
7. The Quantum Group Extends CEOs Employment Agreement
8. Hands on Disaster Response Extends Cyclone Relief Project
9. PROGNOSIS Extends its Popular IP Telephony Management Software to Support Nortel Environments
10. FDA Extends Review Timeline for Additional Indication for Antibiotic DORIBAX(TM)
11. Actavis Extends Portfolio With Four New Products in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2008)... Dr. Alan Greene from the kids, health w...eating only organic food. It,s the same benchmark ...nic. , Danville, CA (PRWE...certified organic by the Department of Agriculture... Alan Greene, why not people?, , , , ,In an artic...
(Date:12/4/2008)...a, Dec. 5 Health Care ...ay launched a global partnership to substitute mer...d affordable alternatives. , , The announce...nference on Alternatives to Mercury in Health Care...the Indian NGO Toxics Link. , , "This initi...
(Date:12/4/2008)...omen using Carraguard had no decrease in infection...lthDay News) -- A microbicidal vaginal gel called ...n. , That,s the conclusion of a study that incl... women at three sites in South Africa. , The wo...and told to use one applicator of gel and a condom...
(Date:12/4/2008)..., Dec. 4 MiddleBrook,Ph...nced that it has opened its,administrative and sa...antown,facility will continue to house certain pe...search and development group. The newly leased 14... house up to 60 employees as MiddleBrook,grows. ,...
Breaking Medicine News(10 mins):Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 2Health News:Dr. Alan Greene: The Organic Man -- Renowned Pediatrician Marks Third Anniversary of Organic-Only Diet 3Health News:Health Care Without Harm, WHO Announce Partnership for Global Reduction of Mercury-Based Medical Devices 2Health News:Experimental Vaginal Gel Doesn't Ward Off HIV 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 2Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 3Health News:Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas 4
...here are certain conditions under which they loose... proteins leading to protein aggregation called as...e for causing neurodegenerative disorders such as ...am from Universitat Autònoma de Barcelona, led by ...
...be effectively fused with other cells to work else...ng to a study.// Researchers at Oregon Health and ...cells may be useful in fighting disease. The rese...Grompe, showed that mice with a disease called tyr...
...Wednesday doctors and hospitals in the global heal...Rs 100 million.// Six hospitals in Chennai, two in... residences of 14 prominent doctors were raided by...Rs.6 million in cash as well as fixed deposits and...
...e responsible for transferring the amino acid Cyst...ucing oxidative stress as Cysteine present in glut...nging activity in brain.// Free radicals are respo...y antioxidants. Professor Raymond Swanson and his ...
Other Medicine News:
(Date:12/3/2008)... potential in newly diagnosed patients with a life...o oral sessions at ASH , , - Exjade results...d patients by significantly reducing toxic iron th...m data from major independent breast cancer trial ...nt strategy, Femara vs. tamoxifen , , - Mul...
(Date:12/3/2008)...irstCall/ -- Wyeth Pharmaceuticals,a division of... submitted a,marketing authorization application ... approval to market its investigational 13-valent ...s and young children. Wyeth is seeking an,indica...D) caused by the 13,serotypes included in the inv...
(Date:12/2/2008)... -- Researchers using functional,MRI (fMRI) have ...rain,responsible for suppressing memory is dysfun... psychiatric disorders. Results of the study will ...adiological Society of North America,(RSNA). , ... stress-related disorders,traumatic memories are...
(Date:12/2/2008)...rizon Therapeutics, Inc., a,privately held biopha...tal,Phase 3 trials evaluating its lead investigat... endpoints. HZT-501, a novel, proprietary fixed-do...amotidine, demonstrated a,statistically significa...ti-inflammatory drug (NSAID)-induced upper gastroi...
Breaking Medicine Technology:More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 2More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 3More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 4More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 5More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 6More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 7More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 8More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 9More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 10More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 11More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 12More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 13More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 14More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 15More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 16More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 17More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 18More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 19More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 20More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 21More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies 22Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 2Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 3Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 4Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children 5Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4AEterna Zentaris to Present at Upcoming Oppenheimer 19th Annual Healthcare Conference 8642 1Severe Health Risks Follow Adults Who Were Diagnosed With Nonalcoholic Fatty Liver Disease as Children 27859 1Severe Health Risks Follow Adults Who Were Diagnosed With Nonalcoholic Fatty Liver Disease as Children 27859 2LCA Vision Reports Third Quarter 2008 Financial Results 27857 1LCA Vision Reports Third Quarter 2008 Financial Results 27857 2LCA Vision Reports Third Quarter 2008 Financial Results 27857 3LCA Vision Reports Third Quarter 2008 Financial Results 27857 4LCA Vision Reports Third Quarter 2008 Financial Results 27857 5LCA Vision Reports Third Quarter 2008 Financial Results 27857 6LCA Vision Reports Third Quarter 2008 Financial Results 27857 7LCA Vision Reports Third Quarter 2008 Financial Results 27857 8LCA Vision Reports Third Quarter 2008 Financial Results 27857 9LCA Vision Reports Third Quarter 2008 Financial Results 27857 10LCA Vision Reports Third Quarter 2008 Financial Results 27857 11LCA Vision Reports Third Quarter 2008 Financial Results 27857 12LCA Vision Reports Third Quarter 2008 Financial Results 27857 13Frost 26 Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 27855 1Frost 26 Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 27855 2Frost 26 Sullivan to Present the 2008 Excellence in Healthcare Innovation Awards 27855 3
...ON, March 06, 2007 /PRNewswire/ -- Up to two milli...p to 600,000,hospitalized. Its primary complicatio...ives annually -- more than breast cancer and,AIDS ...sease may be,at increased risk for DVT, because th...clots and pooling. Respiratory tract infection,may...
...E, Mass., March 06, 2007 /PRNewswire-FirstCall/ --... three completed,Phase III multi- center clinical ...acement therapeutic will be presented during,the N...al Meetings,taking place April 10th through 14th i...a are scheduled to be presented on,Wednesday, Apri...
Other Medicine Technology:DVT Awareness Survey Findings: Heart and Respiratory Patients 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 2Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 3Advanced Magnetics Announces Presentation of Ferumoxytol Data at,the National Kidney Foundation 2007 Spring Clinical Meetings 4
The Estradiol (E2) Enzyme Immunoassay is intended for the for the quantitative determination of Estradiol (E2) concentration in human serum or plasma.
RIA kit for the quantitative determination of autoantibodies to thyroglobulin in serum.
...an 125I radioimmunoassay designed for,in vitro d... estradiol in serum, for the,investigation of pr...n, and for the,differential diagnosis of amenorr...tion,induction with and without stimulation in,...
Coat-A-Count Estradiol is,a no-extraction, solid-phase 125I,radioimmunoassay designed for in vitro,diagnostic use in the quantitative,measurement of estradiol in serum, for the,differential
Medicine Products: